Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NUT family member 2G (NUTM2G) encodes a nuclear protein found on chromosome 9 and serves as a fusion partner in certain high-grade sarcomas, such as MAD::NUT fusion sarcomas and endometrial stromal sarcomas. While its standalone molecular function is not well-characterized, its disease relevance is as a component of oncogenic gene fusions, particularly in rare cancers where it forms fusions with MXD4 (MXD4::NUTM2G) or similar proteins[1][4]. NUTM2G mutations are also associated with male infertility syndromes, including various forms of spermatogenic failure[3]. No direct pharmacological interventions targeting NUTM2G exist, and its utility is mainly as a molecular marker for specific sarcoma subtypes[1][3][4][5].
Null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NUT family member 2G (NUTM2G).